Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1283, 2001-01, pp. : 11-11
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Abciximab beneficial in younger patients with ACS undergoing PCI
Inpharma, Vol. 1, Iss. 1569, 2007-01 ,pp. :
Access to resources
Recommend
Reteplase + abciximab: alternative reperfusion strategy for MI
Inpharma, Vol. 1, Iss. 1364, 2002-01 ,pp. :
Time delay to reperfusion affects outcome in AMI
Inpharma, Vol. 1, Iss. 1362, 2002-01 ,pp. :
Drug therapy after AMI on the rise
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 493, 2005-01 ,pp. :
Abciximab effective in reducing LV remodeling after angioplasty
Inpharma, Vol. 1, Iss. 1519, 2006-01 ,pp. :